arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

electroCore, Inc.

ECOR
$12.29 ▲ +0.17 (+1.44%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
39 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
30
Health
Poor
Moderately Bearish
auto_awesome

Analytical Summary

electroCore, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap
Dividend Yield
Revenue Growth 28.0%
Op. Margin -29.3%
ROIC -55.8%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -3.14
info Valuation on last close. End-of-day price, Sep 22, 2026.

39-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$9.45M
↑ +28.0%
Net Income Profit after all expenses
$-5.27M
↓ -36.7%
Operating Margin Operating profit as % of sales
-29.3%
↑ +47.1% 6th
FCF / Share Free cash flow per share
$-0.39
↑ +68.7%
Long-Term Debt Long-term obligations
$7.76M
— 0.0%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
7
Financial Health
52
Cash Quality
44

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 39 quarters